Tu1583 MITO-LND AND (E)-AKT INHIBITOR-IV: NOVEL COMPOUNDS INDUCING ENDOPLASMIC RETICULUM STRESS AND ROS ACCUMULATION AGAINST HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Risultati per: Gestione del carcinoma polmonare (cancro al polmone) non a piccole cellule
Questo è quello che abbiamo trovato per te
Tu1578 IMBRAVE150: EXPLORATORY EFFICACY AND SAFETY RESULTS OF HEPATOCELLULAR CARCINOMA (HCC) PATIENTS (PTS) WITH MAIN TRUNK AND/OR CONTRALATERAL PORTAL VEIN INVASION (VP4) TREATED WITH ATEZOLIZUMAB (ATEZO) + BEVACIZUMAB (BEV) VS SORAFENIB (SOR) IN A PH III STUDY
Leggi →
Maggio 2024
463 TGF-β1 INDUCED SOX18 ELEVATION PROMOTES HEPATOCELLULAR CARCINOMA PROGRESSION AND METASTASIS THROUGH TRANSCRIPTIONALLY UPREGULATING PD-L1 AND CXCL12
Leggi →
Maggio 2024
Su1716 ATYPICAL PRESENTATION OF SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A CASE REPORT AND REVIEW OF THE LITERATURE
Leggi →
Maggio 2024
Mo1488 FACTORS ASSOCIATED WITH PROLONGED DISEASE- FREE AND OVERALL SURVIVAL FOLLOWING CURATIVE HEPATIC RESECTION FOR HEPATOCELLULAR CARCINOMA: AN OBSERVATIONAL STUDY
Leggi →
Maggio 2024
252 COMBINATION OF MODIFIED ALBUMIN-BILIRUBIN GRADE AND PLATELET COUNT TO PREDICT VARICES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Tu1321 THE SURGICAL CASES OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA IN SHANXI CHANGZHI HOSPITAL IN CHINA: DEMOGRAPHICS, TUMOR CHARACTERISTICS, AND SURGICAL CARE
Leggi →
Maggio 2024
Tu1485 EARLY POSTOPERATIVE OUTCOME COMPARING CHRONIC PANCREATITIS VS. PANCREATIC HEAD CARCINOMA AFTER PYLORUSPRESERVING PANCREATIC HEAD RESECTION ACCORDING TO TRAVERSO-LONGMIRE AT A UNIVERSITY HOSPITAL
Leggi →
Maggio 2024
Sa1539 ASSOCIATION BETWEEN PAY-FOR-PERFORMANCE AND HEPATOCELLULAR CARCINOMA MORTALITY: INSIGHTS FROM A TAIWAN NATIONWIDE COHORT STUDY
Leggi →
Maggio 2024
358 TRIAMTERENE AND ASINEX 1 INHIBIT NRF2 EXPRESSION IN NRF2MUT ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Leggi →
Maggio 2024
Tu1107 THE IMPACT OF PALLIATIVE CARE IN HOSPITALIZATION COSTS AND INTERVENTIONS IN PATIENTS WITH TERMINAL HEPATOCELLULAR CARCINOMA, A LARGE NATIONWIDE ANALYSIS
Leggi →
Maggio 2024
EP74 COMPARATIVE ANALYSIS OF RESPONSE RATE AND TIME TO PROGRESSION AMONG NON-TRANSPLANT TREATMENT OPTIONS FOR EARLY- TO INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA ACROSS A LARGE, INTEGRATED HEALTHCARE SYSTEM IN NORTHERN CALIFORNIA
Leggi →
Maggio 2024
EP72 HMGB1 PROMOTES MITOCHONDRIAL TRANSFER BETWEEN HEPATOCELLULAR CARCINOMA CELLS THROUGH RHOT1 AND RAC1 UNDER HYPOXIA
Leggi →
Maggio 2024
Tu1620 LIVING DONOR LIVER TRANSPLANT FOR HEPATOCELLULAR CARCINOMA IN THE POST “MEDIAN MELD MINUS 3” ERA
Leggi →
Maggio 2024
Tu1619 METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) IS ASSOCIATED WITH LOWER POST-LIVER TRANSPLANT GRAFT SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Leggi →
Maggio 2024
Mo1471 HEPATITIS B VERSUS HEPATITIS B DELTA CO-INFECTION AND RISK OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC LIVER
Leggi →
Maggio 2024
